PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-07

Date Title Company
07-Feb-2024 argenx Announces MHRA Licensing of Subcutaneous VYVGART® ▼ (efgartigimod alfa) for generalised Myasthenia Gravis argenx
07-Feb-2024 argenx Announces MHRA Licensing of Subcutaneous VYVGART® ▼ (efgartigimod alfa) for generalised Myasthenia Gravis argenx
07-Feb-2024 TruLab Integration to Florence Streamlines Biospecimen Data Management for Clinical Sites AccessWire
07-Feb-2024 Cloud DX Receives $770,000 Order for New Technology Devices and Services AccessWire
07-Feb-2024 TuHURA Biosciences, Inc. Appoints Dennis Yamashita, Ph.D., as Chief Scientific Officer and Head of Discovery Research and Early Development AccessWire
07-Feb-2024 Get Well Named #1 Market Leader for Patient-Driven Care Management by KLAS AccessWire
07-Feb-2024 Myrobalan Therapeutics Receives a Grant from the ALS Association to Advance its CSF1R Inhibitor Program Businesswire
07-Feb-2024 Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience Businesswire
07-Feb-2024 Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference Businesswire
07-Feb-2024 Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo in Resectable Non-Small Cell Lung Cancer Businesswire
07-Feb-2024 Global Flexible Industrial Packaging Market Outlook 2023-2036: Plastic Material Dominates, Rising Demand for Sustainable Packaging Driving Growth - ResearchAndMarkets.com Businesswire
07-Feb-2024 Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering AccessWire
07-Feb-2024 Watson-Marlow Fluid Technology Solutions to Showcase Fluid Path Product Range at ISPE Rocky Mountain and ISPE CaSA   Sciad Newswire
07-Feb-2024 Delta-Fly Pharma Inc.: Abstracts submission for Phase I Clinical Trial of DFP-14927 to 2024 ASCO annual meeting Businesswire
07-Feb-2024 ATS Reports Third Quarter Fiscal 2024 Results Businesswire
07-Feb-2024 Invitation to Presentation of Cantargia’s Year-End Report 2023 on February 22 at 3.00 p.m. CET AccessWire
07-Feb-2024 Phoreus Biotech Appoints David Schaefer as CEO to Lead Development of Innovative Drug Delivery Nanocarriers AccessWire
07-Feb-2024 Tribun Health Clinches Best in KLAS Award for the Third Consecutive Year AccessWire
07-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
07-Feb-2024 Senzime Licensee Fukuda Denshi Launches Integrated TetraGraph Module in Japanese Market AccessWire